C

    Climb Bio Inc (CLYM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.73
    -0.84 (-5.77%)

    Market Cap: $836.85M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(10/18)
    Avg Surprise
    +9.31%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.20
    Range$-0.23 - $-0.16
    8 analysts
    EPS Revisions
    2
    0
    7d
    2
    1
    30d
    EPS Estimate Drift
    90d ago$-0.21-8.4%
    60d ago$-0.21-8.4%
    30d ago$-0.21-8.4%
    7d ago$-0.20-1.9%
    Current$-0.20
    Revenue Consensus
    $0
    Range$0 - $0
    15 analysts
    Dec 31, 2026
    EPS Consensus$-0.07
    Range$-0.14 - $0.01
    8 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.07---
    Sep 26EST
    		-$-0.20---
    Jun 26
    		$-0.18$-0.22+18.18%Beat-38.5%
    Mar 26
    		$-0.20$-0.30+33.33%Beat+35.5%
    Dec 25
    		$-0.26$-0.19-38.89%Miss-750.0%
    Sep 25
    		$-0.19$-0.15-26.67%Miss-46.2%
    Jun 25
    		$-0.13$-0.18+27.78%Beat+92.8%
    Mar 25
    		$-0.31$-0.15-106.67%Miss-404.9%
    Dec 24
    		$0.04N/A+126.67%Beat+130.4%
    Sep 24
    		$-0.13N/AN/ABeat+11.3%
    Jun 24
    		$-1.81N/AN/ABeat-830.6%
    Mar 24
    		$-0.06N/AN/ABeat+92.7%
    Dec 23
    		$-0.13$-0.13-1.08%Miss+54.7%
    Sep 23
    		$-0.15$-0.14-4.71%Miss+60.4%
    Jun 23
    		$-0.19$-0.16-21.56%Miss+65.3%
    Mar 23
    		$-0.84$-0.25-236.00%Miss-68.0%
    Dec 22
    		$-0.29$-0.33+12.12%Beat-123.2%
    Sep 22
    		$-0.37$-0.43+13.95%Beat+47.1%
    Jun 22
    		$-0.56$-0.47-19.15%Miss+8.2%
    Mar 22
    		$-0.50$-0.50+0.00%Beat-
    Dec 21
    		$1.25$-0.63+298.41%Beat-
    Sep 21
    		$-0.70$-0.85+17.65%Beat-
    Jun 21
    		$-0.61N/A+74.26%Beat-

    Key Metrics

    Valuation
    P/E Ratio-16.54EV/EBITDA0.59x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-27.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio31.45xQuick Ratio31.45x
    Trading Statistics
    Beta0.08Avg Volume1.24M
    52-Week High$18.3352-Week Low$1.54

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$16.27
    SMA 20$15.30
    SMA 50$13.83
    SMA 200$8.45
    EMA 10$15.48
    EMA 20$15.19
    EMA 50$13.90
    EMA 200$9.46

    MACD

    Line: 0.57Signal: 0.89Hist: -0.32

    ADX

    ADX: 36.4+DI: 23.9-DI: 25.0

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down20.0
    PSAR$17.92

    Bollinger Bands

    Upper Band$18.78
    Lower Band$11.82
    %B Position4553%(Upper)
    Band Width0.27

    RSI (14-Day)

    Neutral
    43.3

    Momentum Oscillators

    Stoch %K22.5
    Stoch %D41.1
    Williams %R-95.0
    ROC (10d)-21.3%
    Momentum-3.71
    CCI (20d)-56.3
    MFI (14d)62.8

    Volatility Measures

    ATR (14d)$1.19(8.7%)
    StdDev (20d)1.74
    Hist Vol94.0%(High)

    Volume Flow

    VWAP$13.97
    OBV77.3M
    AD Line8.7M
    CMF (20d)0.082

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio1.1x
    VWMA (20d)$15.45

    Pivot Points

    R3$15.77
    R2$15.45
    R1$15.01
    Pivot Point$14.69
    S1$14.25
    S2$13.93
    S3$13.49

    Advanced Oscillators

    TSI15.30
    Ultimate Osc38.8
    KST248.85

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$30,000$0$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0$-30,000$0$0$0N/A$0$0$0N/A$0
    Operating Expenses$15.36M$15.21M$19.30M$14.89M$10.68M$23.02M$10.91M$11.73M$56.37M$3.00M$5.12M$5.00M
    R&D$9.71M$9.37M$13.74M$9.07M$6.58M$17.33M$5.96M$6.24M$52.70M$1.09M$3.13M$2.88M
    SG&A$5.64M$5.84M$5.56M$5.82M$4.10M$5.69M$4.95M$5.49M$3.67M$1.91M$2.00M$2.13M
    Operating Income$-15,359,000$-15,211,000$-19,296,000$-14,892,000$-10,677,000$-23,018,000$-10,911,000$-11,732,000$-56,372,000$-3,005,000$-5,122,000$-5,001,000
    Interest Income$1.85M$1.51M$0$2.04M$2.17M$2.29M$0$2.79M$1.49M$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-13,498,000$-13,722,000$-17,516,000$-12,888,000$-8,666,000$-20,781,000$-8,416,000$-8,895,000$-54,889,000$-1,697,000$-3,641,000$-3,968,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-13,498,000$-13,722,000$-17,516,000$-12,888,000$-8,666,000$-20,781,000$-8,416,000$-8,895,000$-54,889,000$-1,697,000$-3,641,000$-3,968,000
    EBITDA$-15,706,000$-15,503,000$-19,777,000$-15,419,000$-11,372,000$-23,737,000$-11,436,000$-11,849,000$-56,374,000$-3,068,000$-5,468,000$-5,754,000
    EBIT$-15,353,000$-15,236,000$-19,296,000$-14,925,000$-10,839,000$-23,068,000$-10,911,000$-11,680,000$-56,374,000$-3,005,000$-5,122,000$-5,001,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CLYM

    Frequently Asked Questions About CLYM

    Does CLYM pay dividends?
    Climb Bio Inc (CLYM) does not currently pay a regular dividend.
    What is CLYM's market cap?
    Climb Bio Inc (CLYM) has a market capitalization of $836.85M with a current stock price of $13.73.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In